Syndax to Host ASH Investor Event in Person and via Webcast on December 14, 2026
Key Highlights
- ➤Syndax will host an ASH investor event on December 14, 2026
- ➤Event features management and multiple key opinion leaders discussing ASH data
- ➤Live webcast and limited-time replay will be available on Syndax’s website
- ➤Syndax highlights FDA-approved Revuforj and Niktimvo in its oncology pipeline
NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the Company will host an in-person investor event, along with a live webcast, on Monday, December 14, 2026, from 7:00–8:30 a.m. CT / 8:00–9:30 a.m. ET during the 68(th) American Society of Hematology (ASH) Annual Meeting. Members of the Syndax management team will be joined by multiple key opinion leaders to discuss key data presented at the ASH meeting.
A live webcast of the event will be available on the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time.
Get started
Create a free account to read the full story.